PCDx is the most sophisticated & comprehensive next-generation cancer diagnostic test available today.
Total raised: $29M
Investors 3
Funding Rounds 3
| Date | Series | Amount | Investors |
| 21.05.2019 | Series B | $15M | - |
| 16.02.2017 | Series B | $7M | - |
| 16.11.2016 | Series B | $7M | - |
Mentions in press and media 16
| Date | Title | Description |
| 10.03.2021 | London-based Octopus Ventures and 83North back cancer diagnostics AI startup from Israel in £27.3M funding round | The London-based most prominent venture capital firm, Octopus Ventures and 83North recently backed the AI-powered cancer diagnostics startup from Israel – Ibex Medical Analytics – in a £27.3 million Series B funding round. Along with Octopu... |
| 10.01.2020 | Cancer Diagnostics Startup Lands $400K From WARF, Northwestern Mutual | PROMISS Diagnostics, a startup that is developing a noninvasive, commercialized screening test for ovarian cancer that uses a machine learning algorithm to distinguish between a benign and malignant mass, has closed on $400,000 in capital t... |
| 21.05.2019 | Paradigm Diagnostics Raises $15M in Series B Funding | Paradigm Diagnostics, a Phoenix, AZ-based precision medicine company focused on cancer diagnostics, raised $15m in Series B funding. Backers included founding investors Mesa Verde Venture Partners, New Science Ventures, Prairie Ventures, Go... |
| 15.05.2019 | Paradigm Diagnostics Closes $15M in Series B | PHOENIX, AZ, Precision medicine company announced the closing of a $15 million Series B fundraising. >> Click here for more funding data on Paradigm Diagnostics >> To export Paradigm Diagnostics funding data to PDF and Excel... |
| 06.09.2017 | Sequoia leads $6 mn round in cancer diagnostics startup OncoStem | OncoStem Diagnostics Pvt. Ltd, which develops prognostic and predictive tests for cancer treatment, has raised $6 million (Rs 38.5 crore) in a funding round led by Sequoia Capital India, it said in a press statement. Silicon Valley-based Ar... |
| 17.02.2017 | Term Sheet — Friday, February 17 | IT’s TIME TO TAKE AI SERIOUSLY The following is from the latest print edition of Fortune, where I write a regular column about technology and startups called “💥Boom with a View💥.” Paid Content You can't secure what you can't see From ExtraH... |
| 16.02.2017 | Term Sheet — Thursday, February 16 | SNAP CRACKLE DROP Snap goes low: Either Snap is setting itself up for a big pop, or the company’s underwriters are nervous about how the market reacted to Snap’s slowing growth and major losses. Paid Content How can you protect what you can... |
| 16.02.2017 | Paradigm Diagnostics Raises $7M in Series B Funding | Paradigm Diagnostics, a Phoenix, AZ-based provider of a cancer diagnostic test, near completed its $7M Series B financing. The company, which added an additional $3M from New Sciences Ventures on top of the $3.5M led by Mesa Verde Venture P... |
| 16.02.2017 | Paradigm Diagnostics Announces $7M Series B Funding | Paradigm Diagnostics today announced the near completion of their $7M Series B financing, adding an additional $3M from New Sciences Ventures on top of the $3.5M led by Mesa Verde Venture Partners and other strategic partners at the end of ... |
| 16.11.2016 | Paradigm Diagnostics Announces $7M Series B | PHOENIX, AZ, Paradigm Diagnostics today announced the first closing of a $7 million Series B financing. >> Click here for more funding data on Paradigm Diagnostics >> To export Paradigm Diagnostics funding data to PDF and Ex... |
Show more